Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Galvanize Therapeutics

Explore full profile

Designs and develops pulsed electric field systems to achieve meaningful, and lasting therapeutic outcomes for patients

San Carlos, United StatesFounded 2015Health Tech & Medtech
Valuation $500M–1B Last recorded · 2025
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Galvanize Therapeutics and the history behind them.

About Galvanize Therapeutics

Galvanize is a pioneering startup operating in the medical device technology sector, specifically focusing on energy-based solutions. The company's primary product is the Aliya platform, a groundbreaking technology designed to influence biological processes. Galvanize's initial focus is on chronic bronchitis, cardiac arrhythmias, oncology, and drug delivery, aiming to transform energy into therapeutic solutions.

The company's target market includes healthcare providers and patients suffering from these chronic conditions. Galvanize operates in the medical device industry, a sector known for its high potential for growth and innovation. The business model revolves around the development, marketing, and sale of its Aliya platform and other energy-based medical devices.

Revenue is generated through the sale of these devices to healthcare providers and institutions. The company's leadership team, including Senior Vice President of Sales & Marketing, Michael, brings extensive commercial experience in the Electrophysiology market, which is expected to contribute to the company's growth and market penetration.

Galvanize is backed by ATP (Apple Tree Partners), a prominent life sciences venture capital firm. This partnership provides Galvanize with financial support and strategic guidance, enhancing its potential for success in the competitive medical device market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
San Carlos, United States
Employees
171
Open positions
10
Dealroom signal
91.8/100
Industry
Health, Energy
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Oncology, Cardiology and cardiovascular, Respiratory, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Sep 2022
Capital deployed
—
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Sep 2025 $100M $400M Norwest Venture Partners · Janus Henderson Investors · Ally Bridge Group · T. Rowe Price ↗
SERIES BOther financing Sep 2022 $100M $400M Intuitive Surgical · Fidelity Investments · Apple Tree Partners · Gilmartin Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Galvanize Therapeutics website traffic

Latest recorded traffic for Galvanize Therapeutics is 2.7K monthly website visits, up 3.8% over the last three months. Galvanize Therapeutics's team grew 12.5% over the past year.

Latest monthly visits2.7K 3-month web change+3.8% 1-year team growth+12.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later8 investors entered at this stage

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States97.2%
🇫🇷 France0.9%
🇮🇹 Italy0.9%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Galvanize Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Galvanize Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.